key: cord-0729563-48op2xok
authors: Mohr, Nicholas M.; Harland, Karisa K.; Krishnadasan, Anusha; Eyck, Patrick Ten; Mower, William R.; Willey, James; Chisolm-Straker, Makini; Lim, Stephen C.; McDonald, L. Clifford; Kutty, Preeta K.; Hesse, Elisabeth; Santibanez, Scott; Talan, David A.; Bahamon, Monica; Carlson, Jestin N.; Driver, Brian; Faine, Brett; Galbraith, James; Giordano, Philip A.; Haran, John P.; Higgins, Amanda; Hinson, Jeremiah; House, Stacey; Idris, Ahamed H.; Kean, Efrat; Krebs, Elizabeth; Kurz, Michael C.; Lee, Lilly; Liang, Stephen Y.; Montoy, Juan Carlos C.; Moran, Gregory; Nandi, Utsav; Pathmarajah, Kavitha; Paxton, James H.; Perez, Yesenia; Richardson, Lynne D.; Rodriguez, Robert M.; Rothman, Richard; Schrading, Walter A.; Shuck, Jessica; Slev, Patricia; Smithline, Howard A.; Souffront, Kimberly; Steele, Mark; Stubbs, Amy; Swanson, Morgan; Tiao, Josh; Torres, Jesus R.; Trent, Stacy; Uribe, Lisandra; Venkat, Arvind; Volturo, Gregory; Wallace, Kelli; Weber, Kurt D.
title: Diagnosed and Undiagnosed COVID-19 in US Emergency Department Healthcare Personnel: A Cross-Sectional Analysis
date: 2020-12-17
journal: Ann Emerg Med
DOI: 10.1016/j.annemergmed.2020.12.007
sha: 8f7f0b8003bdc0147cbbecf2bd9951e23c0de6a8
doc_id: 729563
cord_uid: 48op2xok

Objective To determine the percentage of diagnosed and undiagnosed SARS-CoV-2 infection among a sample of US ED health care personnel (HCP) before July 2020. Methods Cross-sectional analysis of ED HCP in 20 geographically diverse university-affiliated EDs from May to July 2020, including case counts of prior laboratory-confirmed COVID-19 diagnoses among all ED HCP, then serology (with confirmatory testing) and reverse transcriptase-polymerase chain reaction (RT-PCR) testing in a sample of volunteers without a previous COVID-19 diagnosis. HCP were categorized as clinical (physicians, advanced practice providers, and nurses) and non-clinical staff (clerks, social workers, and case managers). Previously undiagnosed infection was based on positive SARS-CoV-2 serology or RT-PCR among HCP without prior diagnosis. Results Diagnosed COVID-19 occurred in 2.8% (193/6,788) HCP, and the prevalence was similar for nonclinical and clinical staff (3.8% vs. 2.7%; odds ratio, OR 1.5, 95% confidence interval, 95% CI 0.7-3.2). Among 1,606 HCP without previously diagnosed COVID-19, 29 (1.8%) had evidence of current or past SARS-CoV-2 infection. Most (62%, 18/29) who were seropositive did not think they had been infected, 76% (19/25) recalled COVID-19-compatible symptoms, and 89% (17/19) continued to work while symptomatic. Accounting for both diagnosed and undiagnosed infections, 4.6% (95% CI 2.8-7.5%) of ED HCP were estimated to have been infected with SARS-CoV-2, with 38% of those infections undiagnosed. Conclusions The estimated prevalence of SARS-CoV-2 infection was 4.6%, and over one-third of infections were undiagnosed. Undiagnosed SARS-CoV-2 infection may pose substantial risk for transmission to other staff and patients.

Background SARS-CoV-2 spreads primarily through close personal contact 1,2 , and an analysis of selfreported US and UK data identified that HCP had higher risk of COVID-19 than non-HCP (hazard ratio 3.4). As of November 1, 2020, the Centers for Disease Control and Prevention (CDC) has identified over 200,000 U.S. HCP who have contracted COVID-19. 2, 3 These findings parallel data from the 2003 SARS-1 outbreak that documented HCP transmission-especially for those performing aerosol-generating airway procedures. 4 Importance Emergency department (ED) HCP may be at particularly high risk since they perform resuscitation procedures and frequently treat patients with unknown infection status. 5 Populationbased seroprevalence studies provide evidence that SARS-CoV-2 infection is frequently undiagnosed. [6] [7] [8] Undiagnosed infection among HCP may pose a threat of infection transmission to patients and other HCP.

We describe the prevalence of diagnosed and undiagnosed COVID-19 among US HCP working at 20 geographically diverse US EDs prior to July 2020.

COVID-19 Evaluation of Risks in Emergency Departments (COVERED) is a multicenter prospective surveillance of HCP for SARS-CoV-2 infection at 20 geographically diverse highvolume university-affiliated US hospital EDs (in 15 states, all sites are listed in Acknowledgements) that included assessment of baseline cross-sectional seroprevalence. We collected total COVID-19 case counts identified from among all HCP in participating EDs, then we enrolled a sample of physicians, nurses, advanced practice providers (APPs), and non-clinical HCP (clerks, social workers, case managers, and others without routine patient contact who worked in the ED) not previously diagnosed with COVID-19. This activity was determined to meet the requirements of public health surveillance because it was authorized by a public health authority for assessing risk to HCP in the COVID-19 pandemic as defined in 45 CFR 46.102(l)(2) 9 , and participating HCP provided informed consent. This paper is reported in accordance with Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. 10 

We collected ED facility-level data, including counts of employees' COVID-19 diagnoses from occupational health reports. Additionally, 20 local teams recruited approximately 80 volunteer HCP at each site who had not been diagnosed with COVID-19: 40 physicians/APPs, 20 nurses, J o u r n a l P r e -p r o o f and 20 non-clinical staff (20.8% of eligible employees). The sample size was determined from the parent study to detect an attributable risk of COVID-19 acquisition of 4% (α=0.05, power=0.9). Participants completed a survey about their job and COVID-19 exposures 11 and provided a blood sample and a proctored self-collected nasal swab for baseline serology and SARS-CoV-2 reverse transcriptase-polymerase chain reaction (RT-PCR) testing, respectively.

After these initial results were reported, we asked participants with positive results to provide information about symptoms and exposures since December 31, 2019. We collected COVID-19 community cumulative incidence from public health reports for the health service area (HSA) of each facility as of June 29, 2020.

Nasal swabs were analyzed by SARS-CoV-2 RT-PCR (limit of detection 0.009 median tissue culture infectious dose [TCID 50 ]/mL). Anti-SARS-CoV-2 IgG (nucleocapsid phosphoprotein; sensitivity 100% and specificity 99.6%) was measured using the Architect i2000 (Abbott Laboratories, Chicago, Illinois), with positive serology results confirmed by orthogonal testing using a spike glycoprotein (sensitivity 90% and specificity 100%) ELISA assay (EUROIMMUN, Lubeck, Germany). We designated HCP as testing positive for prior SARS-CoV-2 infection if they had: (1) positive results on both the nucleocapsid and spike IgG assays, or (2) positive nasal PCR.

We calculated summary statistics as counts and percentages (with 95% confidence intervals, adjusted for clustering by site) for categorical variables, and we used medians and IQRs for continuous variables. We calculated odds ratios with adjusted 95% confidence intervals adjusted Figure 1 ). of those who reported symptoms worked in the ED while symptomatic (median 3 days; IQR 2-4).

Our most significant limitation is the risk of applying an estimate of undiagnosed infection from a sample of volunteers to the entire HCP population. Because we did not randomly select HCP for participation in our surveillance testing, our volunteer participants may have been more likely or less likely to include the highest-risk HCP. Our estimates of the burden J o u r n a l P r e -p r o o f of undiagnosed infection come from extrapolation to the larger ED HCP population, but this sampling method introduces uncertainty into our estimate of disease.

Additionally, participating sites were academic centers with infection control programs in place, which may not be fully representative of all US EDs. Our project is further limited by the occupational health data used to tabulate diagnosed COVID-19 cases. Our reliance on occupational health records may have undercounted infections among the non-participating HCP. Recall bias may have affected the quality of data in seropositive participants. The strengths of this project include geographic diversity and rigorous high-accuracy testing procedures.

infections were undiagnosed. Single-site studies of US HCP have shown SARS-CoV-2 seropositivity rates between 0.4% and 46%, 5,12 and a recent multisite seroprevalence survey of frontline HCP estimated a seropositivity at 6%. 13 Our methods differ from the prior multisite study in that we enrolled both clinical and non-clinical staff in EDs only, reported occupational health data, and used an orthogonal serology testing strategy specifically designed to limit false positive tests. That one-third of infections were undiagnosed highlights the importance of infection control strategies not only to prevent HCP infections (e.g., use of personal protective equipment [PPE]) but also to limit spread from HCP to others (e.g., universal use of masks). 14 Recognition of SARS-CoV-2 infection by HCP was unreliable, with over 60% of those infected unaware that they had COVID-19. Many of these HCP worked during a period when they had COVID-compatible symptoms, either because their infection was early in the pandemic, J o u r n a l P r e -p r o o f symptoms were perceived as trivial, or negative PCR testing reassured them it was safe to work.

Additionally, about one-quarter of infections appeared to be asymptomatic. Enhanced PPE use by HCP, HCP surveillance for infection, non-punitive workplace illness measures, and priority access to potential vaccine may decrease the risk of viral transmission from HCP to vulnerable patients and help maintain an effective frontline healthcare workforce. Ultimately, COVERED is an ongoing prospective surveillance project determining rates of new infections among clinical and non-clinical ED HCP that will collect information on specific exposures, infection control practices, PPE use, and community and household contacts to better determine the attributable risk of ED patient care.

We did not find a higher prevalence of infection in clinical compared to nonclinical staff, suggesting that the risk from direct ED patient care in these sites may be relatively small. The Table 2 ). White bars show the cumulative community COVID-19 incidence (June 29, 2020, right vertical axis). In total, 38% of all infections among ED HCP were undiagnosed prior to PCR and serology testing. B. The relationship between the percentage of recognized and estimated unrecognized infections in this sample, stratified by job classification. Gray bars represent diagnosed infections, and black bars represent undiagnosed infections. 

Update Alert: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers

Risk of COVID-19 among front-line healthcare workers and the general community: a prospective cohort study. The Lancet Public Health

Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series

COVID-19 Seroconversion in Emergency Professionals at an Urban Academic Emergency Department

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Natural History of Asymptomatic SARS-CoV-2 Infection

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

Definitions for the purposes of this policy. Code of Federal Regulations (CFR)

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet

COVID-19 Evaluation of Risk in Emergency Departments (Project COVERED)

Occupational Exposures and Programmatic Response to COVID-19 Pandemic: An Emergency Medical Services Experience. medRxiv

Among Frontline Health Care Personnel in a Multistate Hospital Network -13

Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital

Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China

advanced practice provider; 95% CI, 95% confidence interval; HCP, health care personnel

The authors would like to acknowledge the following participating Project COVERED emergency departments: Allegheny 

J o u r n a l P r e -p r o o f